文献速递认知障碍与痴呆

β-淀粉样蛋白积累与认知未受损成人执行功能的相关性

Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
PubMed 文献 · Neurology · 2022-01-12

这项横断面研究纳入 BioFINDER-2 研究的 316 名认知未受损参与者,分析脑脊液 Aβ42、p-tau181、Aβ-PET、tau-PET 及皮层厚度与各认知域的关系,并在 ADNI 队列(n=361)中总体重复。结果显示 Aβ 状态独立关联执行功能而非记忆,tau 独立关联记忆。

要点

  • 在认知未受损人群中,Aβ 状态独立关联执行功能,与记忆无关。
  • tau 独立关联记忆表现,与执行功能无关。
  • 皮层厚度独立关联执行功能与言语流畅性。

核心结论

  • Aβ 独立关联执行功能较差表现但不关联记忆表现,记忆表现则与 tau 病理相关。
  • 作者认为这可能对早期临床前 AD 筛查及针对 Aβ 病理的 AD 试验结局指标有启示。

研究设计与样本

  • 横断面研究,纳入前瞻性 BioFINDER-2 研究中认知未受损参与者 316 名。
  • 所有参与者均有脑脊液 Aβ42 和 p-tau181、MRI 皮层厚度、Aβ-PET 新皮层摄取、tau-PET 内嗅皮层摄取及记忆、执行功能、言语功能、视空间功能认知测试数据。
  • 采用多变量线性回归模型,分别以脑脊液 Aβ42、p-tau181 与皮层厚度,或 Aβ-PET、tau-PET 与皮层厚度为预测因子。
  • 结果在独立队列 ADNI(n=361)中验证。

主要发现

  • 异常 Aβ 状态独立关联执行功能指标,无论模态(脑脊液 Aβ42,β=0.128,p=0.024;Aβ-PET,β=0.124,p=0.049)。
  • tau 独立关联记忆(脑脊液 p-tau181,β=0.132,p=0.018;tau-PET,β=0.189,p=0.002)。
  • 皮层厚度在两个模型中均独立关联执行功能指标与言语流畅性(p=0.005-0.018)。
  • 仅纳入 tau 与神经变性生物标志物正常者(脑脊液组 n=217;PET 组 n=246)时,Aβ 状态仍关联执行功能(脑脊液 Aβ42,β=0.189,p=0.005;Aβ-PET,β=0.146,p=0.023),但不关联其他认知域。
  • 结果在 ADNI 队列(n=361)中总体重复。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The neuropathologic changes underlying Alzheimer disease (AD) start before overt cognitive symptoms arise, but it is not well-known how they relate to the first subtle cognitive changes. The objective for this study was to examine the independent associations of the AD hallmarks β-amyloid (Aβ), tau, and neurodegeneration with different cognitive domains in cognitively unimpaired (CU) individuals. METHODS: In this cross-sectional study, CU participants from the prospective BioFINDER-2 study were included. All had CSF biomarkers (Aβ42 and phosphorylated tau [p-tau]181), MRI (cortical thickness of AD-susceptible regions), Aβ-PET (neocortical uptake), tau-PET (entorhinal uptake), and cognitive test data for memory, executive function, verbal function, and visuospatial function. Multivariable linear regression models were performed using either CSF Aβ42, p-tau181, and cortical thickness or Aβ-PET, tau-PET, and cortical thickness as predictors of cognitive function. The results were validated in an independent cohort (Alzheimer's Disease Neuroimaging Initiative [ADNI]). RESULTS: A total of 316 CU participants were included from the BioFINDER-2 study. Abnormal Aβ status was independently associated with the executive measure, regardless of modality (CSF Aβ42, β = 0.128, p = 0.024; Aβ-PET, β = 0.124, p = 0.049), while tau was independently associated with memory (CSF p-tau181, β = 0.132, p = 0.018; tau-PET, β = 0.189, p = 0.002). Cortical thickness was independently associated with the executive measure and verbal fluency in both models (p = 0.005-0.018). To examine the relationships in the earliest stage of preclinical AD, only participants with normal biomarkers of tau and neurodegeneration were included (n = 217 CSF-based; n = 246 PET-based). Again, Aβ status was associated with executive function (CSF Aβ42, β = 0.189, p = 0.005; Aβ-PET, β = 0.146, p = 0.023), but not with other cognitive domains. The results were overall replicated in the ADNI cohort (n = 361). DISCUSSION: These findings suggest that Aβ is independently associated with worse performance on an executive measure but not with memory performance, which instead is associated with tau pathology. This may have implications for early preclinical AD screening and outcome measures in AD trials targeting Aβ pathology.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tideman P, Stomrud E, Leuzy A, et al. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition. Neurology. 2022. PMID: 35022305. doi:10.1212/WNL.0000000000013299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。